From: Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
Per-protocol population
Demographic
(n = 81)
Age
Mean ± SD, y
58.3 ± 11.4
Race, n (%)
Black
50 (62)
White
28 (34)
Asian
3 (4)
Sex, n (%)
Male
27 (33)
Female
54 (67)